The global first umbilical cord one serves as stem cell's

The global first umbilical cord one serves as stem cell's scale of the storehouse of the quality to run
It is reported ' Reporter Feng GuoWu) Fill stem cell's storehouse of the quality among what the national project research center of the cell products undertakes the construction of in the world and first, more than operation succeed in, store the intersection of umbilical cord and room, fill quality nearly 5000 of stem cell already through last one year, succeed in starting the operation of scale.

The cell products was sanctioned setting up by the national development and reform committee in 2004 in national project research center, Tianjin hold high comparable to the intersection of cell and the intersection of genetic engineering and Co., Ltd., undertake research and development of centre and run, work independently as the intersection of project legal person and unit their. Under the leading of centre the director, foreign academician Professor Han Zhongchao of French academy of medical sciences, the centre has solved and organized separating, training one to fill the quality this sophisticated technology of the stem cell from the umbilical cord at first in the world, invent a kind of patented technology ' People's placenta, umbilical cord one serve as stem cell's storehouse of the quality and construct the method) ,And succeed in utilizing this patented technology to fill stem cell's storehouse of the quality while setting up in the world firstly. Utilizing this patented technology, they have also prepared a stem cell and treated the new products - --The umbilical cord one serves as quality parenteral solution of stem cell. Prove by experiment by animal, to old and feeble and many kinds of disease that damage cause the parenteral solution, the immune rejection syndrome after paralysis and hematopoietic stem cell are transplanted as the heart disease, nerve are damaged to cause has prominent therapeutic effects, the centre has already possessed and produced a ability to fill quality parenteral solution of stem cell of umbilical cord in batches tentatively at present, declare the work to already launch in clinical practice about country new medicine.

It is reported, " stem cell's key technology and industrialization project of product development " that the national project research center of the cell products heads the list of signers and undertakes Classified as Tianjin and confirmed the great project of 20 autonomous innovation industrialization implemented recently. Develop the umbilical cord one and fill the quality stem cell and treat products and genetic engineering and recombinate new medicines such as PF4 and HAPO,etc. in main content, break through the umbilical cord one and fill the quality stem cell and separate, train and store key technology on a large scale.




The global first umbilical cord one serves as stem cell's scale of the storehouse of the quality to run